1. Targeting α 1 - and α 2 -adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression.
- Author
-
Shaykin JD, Denehy ED, Martin JR, Chandler CM, Luo D, Taylor CE, Sunshine MD, Turner JR, Alilain WJ, Prisinzano TE, and Bardo MT
- Subjects
- Animals, Male, Receptors, Adrenergic, alpha-1 metabolism, Adrenergic alpha-1 Receptor Antagonists pharmacology, Rats, Locomotion drug effects, Analgesics, Opioid pharmacology, Narcotic Antagonists pharmacology, Yohimbine pharmacology, Naltrexone pharmacology, Naltrexone analogs & derivatives, Adrenergic alpha-2 Receptor Antagonists pharmacology, Respiration drug effects, Fentanyl pharmacology, Rats, Sprague-Dawley, Receptors, Adrenergic, alpha-2 metabolism
- Abstract
This study assessed the ability of α
1 and α2 -adrenergic drugs to decrease fentanyl-induced locomotor and ventilatory depression. Rats were given saline or fentanyl, followed by: (1) naltrexone, (2) naloxone, (3) nalmefene, (4) α1 agonist phenylephrine, (5) α1 antagonist prazosin, (6) α1D antagonist BMY-7378, (7) α2 agonist clonidine, (8) α2 antagonist yohimbine or (9) vehicle. All µ-opioid antagonists dose-dependently reversed fentanyl-induced locomotor and ventilatory depression. While the α1 drugs did not alter the effects of fentanyl, clonidine dose-dependently decreased locomotion and respiration with and without fentanyl. Conversely, yohimbine given at a low dose (0.3-1 mg/kg) stimulated ventilation when given alone and higher doses (>1 mg/kg) partially reversed (∼50 %) fentanyl-induced ventilatory depression, but not locomotor depression. High doses of yohimbine in combination with a suboptimal dose of naltrexone reversed fentanyl-induced ventilatory depression, suggestive of additivity. Yohimbine may serve as an effective adjunctive countermeasure agent combined with naltrexone to rescue fentanyl-induced ventilatory depression., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF